Anika Therapeutics News

Anika Therapeutics | 8-K: Current report

May 8 17:19 ET

Anika Therapeutics | 8-K: Anika Reports First Quarter 2024 Financial Results

May 8 16:15 ET

Anika Therapeutics | 8-K: Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Mar 13 16:15 ET

Anika Therapeutics | 8-K: Current report

Feb 26 09:05 ET

Anika Therapeutics | S-8 POS: S-8 POS

Jan 22 00:00 ET

Anika Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 19 00:00 ET

Anika Therapeutics | 8-K: Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business

Nov 2, 2023 16:11 ET

Anika Therapeutics | 8-K: Current report

Sep 21, 2023 07:55 ET

Anika Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 8, 2023 17:18 ET

Anika Therapeutics | 8-K: Anika Reports Second Quarter 2023 Financial Results

Aug 8, 2023 16:11 ET

Anika Therapeutics | 8-K: Current report

Jun 21, 2023 16:50 ET

Anika Therapeutics | 8-K: Anika Reports First Quarter 2023 Financial Results

May 9, 2023 16:11 ET

Anika Therapeutics | DEFA14A: Others

May 1, 2023 17:20 ET

Anika Therapeutics | DEF 14A: Definitive proxy statements

May 1, 2023 17:18 ET

Anika Therapeutics | 8-K: Current report

Apr 28, 2023 08:00 ET

Anika Therapeutics | 8-K: Current report

Apr 13, 2023 17:20 ET

Anika Therapeutics | DEFA14A: Others

Mar 27, 2023 09:02 ET

Anika Therapeutics | 8-K: Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

Mar 6, 2023 16:10 ET

Anika Therapeutics | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Feb 21, 2023 13:19 ET

Anika Therapeutics | 8-K: Anika Reports Third Quarter Fiscal 2022 Financial Results

Nov 8, 2022 16:10 ET